Bovine Respiratory Disease Complex: Bacterial Pathogens and Rapid Diagnostic Approaches

Introduction

Bovine respiratory disease complex (BRDC) represents the most economically significant infectious disease syndrome affecting feedlot cattle worldwide. The condition is multifactorial, arising from the interaction of viral pathogens, environmental stressors, and bacterial opportunists. While primary viral infections such as bovine viral diarrhea virus (BVDV), bovine respiratory syncytial virus (BRSV), bovine parainfluenza virus type 3 (BPIV-3), and bovine coronavirus often initiate respiratory injury, the clinical manifestation of pneumonia is largely attributable to secondary bacterial invaders. This review focuses on the principal bacterial pathogens involved in BRDC, emphasizing Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni, and examines contemporary rapid diagnostic modalities that support targeted antimicrobial therapy and stewardship in feedlot operations.

Primary Bacterial Pathogens

The bacterial etiology of BRDC is dominated by a limited number of species, each possessing distinct virulence mechanisms and epidemiological profiles. The three most commonly isolated bacterial agents are M. haemolytica, P. multocida, and H. somni. A fourth organism, Mycoplasmopsis bovis (formerly Mycoplasma bovis), is increasingly recognized as a significant contributor to chronic pneumonia and arthritis in calves [1]. Understanding the biological and biophysical interactions of these pathogens with the host respiratory epithelium is essential for rational diagnostic and therapeutic decision making.

Mannheimia haemolytica

M. haemolytica is the most frequently isolated bacterial pathogen from acute cases of BRDC in feedlot cattle. The organism is a gram-negative coccobacillus that resides as a commensal in the upper respiratory tract. Following viral infection or stress-induced immunosuppression, the bacterium proliferates in the nasopharynx and is aspirated into the lower airways.

The primary virulence determinant of M. haemolytica is a leukotoxin belonging to the repeats-in-toxin (RTX) family. This exotoxin specifically targets ruminant leukocytes, including alveolar macrophages and neutrophils, by binding to the CD18 subunit of β2 integrins. At sublytic concentrations, the leukotoxin triggers the release of proinflammatory cytokines, including interleukin-8 and tumor necrosis factor-α, which amplify neutrophil recruitment into the alveolar space. At lytic concentrations, the toxin induces cellular necrosis and degranulation, releasing degradative enzymes and reactive oxygen species that cause extensive pulmonary parenchymal damage. The resulting lesions are characterized by fibrinonecrotic pleuropneumonia, which is clinically associated with severe dyspnea, pyrexia, and high mortality if untreated.

Additional virulence factors include a polysaccharide capsule that inhibits phagocytosis, lipopolysaccharide (LPS) that activates the complement cascade, and outer membrane proteins that facilitate adhesion to respiratory epithelium. Genomic analyses have revealed considerable diversity among M. haemolytica isolates, with serotypes A1 and A6 being most prevalent in bovine respiratory disease [14]. The genomic plasticity of this organism has implications for vaccine design and diagnostic target selection [14].

Pasteurella multocida

P. multocida is a gram-negative coccobacillus frequently isolated from BRDC cases, particularly in younger calves and in animals with subacute or chronic pneumonia. While P. multocida is considered a primary pathogen in avian species, its role in bovine respiratory disease is often as a secondary invader following viral or M. haemolytica infection. However, clinical evidence supports its ability to cause substantial lung pathology independently under conditions of host susceptibility [2].

Virulence factors of P. multocida include a hyaluronic acid capsule, which provides antiphagocytic properties, and a lipopolysaccharide with endotoxic activity. The organism also expresses fimbriae and outer membrane proteins that facilitate adherence to respiratory epithelium. Genomic studies of P. multocida isolates from bovine respiratory cases have demonstrated considerable diversity, including the presence of extracellular enzymes and iron acquisition systems that enhance survival within the host [2]. Capsular serogroups A and F are most commonly associated with bovine pneumonia.

Histopathologically, P. multocida infection tends to produce a suppurative bronchopneumonia with a cranioventral distribution, often complicated by fibrinous pleuritis. In feedlot settings, coinfection with M. haemolytica and P. multocida is common and is associated with more severe clinical disease.

Histophilus somni

H. somni is a gram-negative coccobacillus that is part of the normal flora of the bovine upper respiratory tract and reproductive tract. Under conditions of stress and viral coinfection, H. somni can cause a range of clinical syndromes, including pneumonia, myocarditis, thrombotic meningoencephalitis, and suppurative arthritis. In the context of BRDC, H. somni is a significant contributor to fibrinous pleuropneumonia, particularly in feedlot cattle.

The pathogenicity of H. somni is mediated by several virulence factors. The organism possesses a lipooligosaccharide that undergoes phase variation, allowing evasion of host immune responses. H. somni also expresses a repertoire of outer membrane proteins, including a histidine-rich protein (HrpA) that facilitates iron acquisition and survival within the host. A key virulence determinant is the ability of H. somni to survive and replicate within pulmonary macrophages, a trait that contributes to chronic infection and therapeutic failure.

Infection with H. somni frequently results in a multifocal necrotizing bronchopneumonia with thrombosis of pulmonary vessels. The organism's capacity to induce vasculitis distinguishes it from M. haemolytica and P. multocida and may be linked to the development of the disseminated intravascular coagulation observed in some peracute cases.

Additional Bacterial Pathogens

M. bovis is a cell-wall-deficient bacterium that has emerged as a major cause of chronic, treatment-resistant pneumonia and arthritis in weaned and feedlot calves. Unlike the gram-negative pathogens described above, M. bovis lacks a cell wall and is inherently resistant to β-lactam antibiotics. The organism causes a coagulative necrosis and caseous bronchopneumonia with characteristic lymphoid hyperplasia. M. bovis is also notable for its ability to suppress the host immune response and to persist within the lower respiratory tract for extended periods. Coinfection with M. bovis and other BRDC pathogens is common and is associated with increased lesion severity and reduced therapeutic efficacy [1].

Other bacteria isolated less frequently from BRDC cases include Trueperella pyogenes, Fusobacterium necrophorum, and Bibersteinia trehalosi. These organisms are often associated with secondary infection and abscess formation and may be more prevalent in chronic cases or in animals with concurrent disease.

Rapid Diagnostic Approaches

Traditional diagnosis of BRDC has relied on clinical examination using a standardized scoring system (e.g., the Wisconsin or DART system) combined with thoracic auscultation. While these methods are practical for field use, they lack sensitivity and specificity for identifying the etiological agent. The increasing prevalence of antimicrobial resistance among BRDC pathogens has created an urgent need for rapid, accurate diagnostic tools that can inform targeted therapy [3].

Conventional Microbiological Methods

Culture and antimicrobial susceptibility testing of deep nasopharyngeal swabs or bronchoalveolar lavage fluid remain the reference standard for identifying bacterial pathogens in BRDC. However, these methods are limited by the time required for isolation (typically 48 to 72 hours), the need for viable organisms, and the potential for contamination by commensal flora. Furthermore, culture-based methods underrepresent fastidious organisms such as H. somni and M. bovis, which require specialized media and growth conditions. Despite these limitations, culture remains essential for comprehensive antimicrobial susceptibility profiling and for detecting emerging resistance patterns.

Nucleic Acid Amplification Technologies

Polymerase chain reaction (PCR) and its derivatives represent the most significant advance in rapid BRDC diagnostics. Real-time PCR assays offer high sensitivity and specificity, low limits of detection, and the ability to provide results within one to three hours from sample collection. These assays are widely deployed in veterinary diagnostic laboratories for the detection of bacterial and viral nucleic acids from antemortem and postmortem specimens.

Multiplex PCR Panels

The development of multiplex PCR panels has been a transformative development for BRDC diagnostics. These panels simultaneously detect DNA from multiple bacterial and viral targets in a single reaction, providing a comprehensive etiological profile within a clinically actionable timeframe. Common bacterial targets include M. haemolytica, P. multocida, H. somni, M. bovis, and T. pyogenes. Viral targets often include BVDV, BRSV, BPIV-3, and bovine coronavirus.

Multiplex PCR offers several advantages over single-target PCR. It reduces the amount of sample required, decreases turnaround time, and lowers the overall cost per target. For feedlot operations, multiplex PCR can be used to provide a rapid diagnosis at the pen level, enabling early initiation of targeted therapy and reducing the use of empirical broad-spectrum antimicrobials. The sensitivities of these assays are high, with typical limits of detection in the range of 10 to 100 copies per reaction for most targets.

The utility of multiplex PCR in field settings depends on the selection of appropriate primers and probes. These must target conserved genomic regions to ensure detection of circulating strains. Periodic reassessment of primer and probe sequences is necessary to account for genetic drift and recombination events. In one study, a multiplex PCR panel demonstrated high concordance with bacterial culture for M. haemolytica, P. multocida, and H. somni, but showed lower agreement for M. bovis due to the organism's genomic variability [4]. Similarly, a dual RT-qPCR assay has been developed for differential detection of bovine rhinitis virus genotypes, highlighting the versatility of multiplex approaches for BRDC diagnostics [5].

Point-of-Care PCR

The miniaturization of thermal cyclers and the development of lyophilized reagent formulations have enabled the deployment of PCR at the point of care. These platforms typically use isothermal amplification methods such as loop-mediated isothermal amplification (LAMP) or recombinase polymerase amplification (RPA), which do not require thermal cycling and can be performed with minimal equipment. LAMP assays for M. haemolytica and P. multocida have been reported, with analytical sensitivities comparable to real-time PCR. The advantages of point-of-care PCR include portability, rapid turnaround time (30 to 60 minutes), and ease of use by veterinary practitioners.

However, point-of-care PCR platforms generally accommodate fewer targets than laboratory-based multiplex panels, and their sensitivity may be reduced when sample quality is poor or when inhibitors are present. Their role in BRDC diagnostics is likely to be as a triage tool, providing a preliminary result that guides initial therapy while definitive results are obtained from the diagnostic laboratory.

CRISPR-Based Nucleic Acid Detection

Clustered regularly interspaced short palindromic repeats (CRISPR) technology has been adapted for nucleic acid detection and has potential applications in BRDC diagnostics. The system typically uses a Cas12 or Cas13 nuclease coupled with a guide RNA specific to the target nucleic acid. Upon target binding, the Cas nuclease cleaves a reporter molecule, generating a detectable signal. These assays can be performed at constant temperature and can achieve sub-attomolar sensitivity.

A CRISPR-Cas13a-based amplification-free electrochemical biosensor has been developed for detection of bovine viral diarrhea virus [12]. While this platform has not yet been widely applied to bacterial pathogens, the principle is transferable. CRISPR-based detection offers the advantages of speed, isothermal operation, and low cost compared to conventional PCR. However, the technology remains in the early stages of validation for veterinary applications, and issues with multiplexing and signal interpretation require further refinement.

Metagenomic Sequencing

Metagenomic sequencing represents the most comprehensive approach to BRDC diagnostics. By sequencing all nucleic acid present in a clinical sample, this method provides an unbiased view of the entire microbial community, including bacteria, viruses, fungi, and parasites. Metagenomics can identify unexpected or emerging pathogens, detect coinfections, and characterize the resistome of the microbial population.

Two primary approaches are used: whole genome shotgun metagenomics and targeted amplicon sequencing. Shotgun metagenomics sequences all DNA fragments in the sample, providing information on both the taxonomic composition and the functional gene content, including antimicrobial resistance genes. Amplicon sequencing targets specific genetic markers, such as the 16S rRNA gene for bacteria, to provide a high-resolution taxonomic profile. Both methods generate large datasets that require bioinformatics processing for interpretation.

The application of metagenomic sequencing to BRDC has revealed a greater diversity of microorganisms in the bovine respiratory tract than was previously appreciated [3]. In addition to the canonical pathogens, sequences from Mycoplasmopsis species, T. pyogenes, and various anaerobic organisms are frequently detected, especially in chronic cases. Metagenomics can also identify viral pathogens that are not included in standard PCR panels, providing a more complete picture of the infectious process.

The major barriers to the routine use of metagenomic sequencing in feedlot diagnostics are the cost, complexity, and turnaround time. Bioinformatics analysis requires specialized expertise and computational resources, and the results are typically not available within a clinically actionable window. However, as sequencing costs continue to decline and as automated analysis platforms become more accessible, metagenomics is expected to play an increasing role in BRDC surveillance and outbreak investigation.

Lung Ultrasonography

Lung ultrasonography is a noninvasive, rapid diagnostic tool that can be used at the chute side to identify pulmonary consolidation in cattle with suspected BRDC. The technique uses a portable ultrasound transducer to image the pleural surface and underlying lung parenchyma. The presence of comet tail artifacts, consolidated lung tissue, or pleural effusion is indicative of pneumonia.

The sensitivity and specificity of lung ultrasonography for detecting BRDC have been evaluated in several studies. A Bayesian latent-class modeling approach yielded a pooled sensitivity of approximately 80% and a specificity of 92% for the diagnosis of pneumonia in calves [6]. While ultrasonography cannot identify the etiological agent, it provides objective evidence of lung pathology that can be used to confirm clinical suspicion and guide treatment decisions. Combined with molecular testing, lung ultrasonography can help refine case definitions and improve the accuracy of antimicrobial use decisions.

Antimicrobial Stewardship and Rapid Diagnostics

The overuse of antimicrobials in feedlot operations has contributed to the selection of resistant bacterial strains. The emergence of multidrug-resistant M. haemolytica and M. bovis is of particular concern, as these organisms are associated with treatment failure and increased mortality. Rapid diagnostics are a cornerstone of antimicrobial stewardship programs, as they enable clinicians to differentiate between bacterial and viral infections and to identify the specific bacterial species involved.

Resistance Profiles and Stewardship Implications

Resistance to tetracyclines, macrolides, and fluoroquinolones has been documented in M. haemolytica and P. multocida isolates from feedlot cattle. The mechanisms of resistance include efflux pumps, ribosomal protection proteins, and target-site mutations. For M. bovis, resistance to macrolides is particularly problematic due to mutations in the 23S rRNA gene.

The availability of rapid diagnostic results allows for the selection of antimicrobial agents with a high probability of efficacy, reducing the reliance on empirical broad-spectrum therapy. For example, detection of M. bovis in a respiratory sample should prompt avoidance of β-lactams and consideration of florfenicol or enrofloxacin. Conversely, detection of P. multocida in the absence of M. bovis may allow the use of a narrower-spectrum agent such as oxytetracycline. The integration of diagnostic data with local antimicrobial susceptibility patterns is critical for optimizing therapy.

Integrated Diagnostic Workflow

An integrated diagnostic workflow for BRDC should combine clinical assessment, rapid molecular testing, and antimicrobial susceptibility profiling. The following steps represent a recommended approach for feedlot settings:

1. Clinical evaluation and scoring of suspect animals using a validated clinical illness score.
2. Collection of a deep nasopharyngeal swab or bronchoalveolar lavage sample for testing.
3. On-site deployment of a point-of-care PCR test to identify the presence of common bacterial and viral pathogens within one hour.
4. Submission of the sample for confirmatory multiplex PCR and culture-based antimicrobial susceptibility testing at a reference laboratory.
5. Based on the point-of-care result, initiation of targeted antimicrobial therapy where indicated.
6. Reassessment of clinical response at 48 to 72 hours, with the option to modify therapy based on the final culture and sensitivity results.

This workflow balances speed with accuracy, allowing immediate treatment decisions while enabling definitive characterization of the etiological agent and its resistance profile.

flowchart TD
    A[Clinical Exam and Scoring], > B[Sample Collection]
    B, > C[On-Site Point-of-Care PCR]
    C, > D{Pathogen Detected?}
    D, >|Yes| E[Initiate Targeted Antimicrobial Therapy]
    D, >|No| F[Re-evaluate for Non-Infectious Causes]
    E, > G[Submit Sample for Confirmatory Testing]
    G, > H[Laboratory Multiplex PCR and Culture]
    H, > I[Antimicrobial Susceptibility Testing]
    I, > J[Reassess Therapy at 48-72 Hours]
    J, > K[Adjust or Continue Treatment]
    F, > L[Consider Alternative Diagnostics]

Conclusion

The bacterial pathogens associated with BRDC represent a persistent challenge to feedlot health and productivity. M. haemolytica, P. multocida, H. somni, and M. bovis each possess distinct virulence strategies that dictate their clinical and pathological manifestations. Rapid diagnostic technologies, particularly multiplex PCR and point-of-care nucleic acid amplification assays, have substantially improved the ability to identify these pathogens in a clinically relevant timeframe. The emergence of CRISPR-based detection methods and the increasing availability of metagenomic sequencing promise to further expand the diagnostic toolkit. The integration of rapid diagnostics into antimicrobial stewardship programs is essential for preserving the efficacy of existing antimicrobials and for improving treatment outcomes in BRDC. Successful implementation requires continued investment in assay validation, practitioner education, and bioinformatics infrastructure.

References

[1] Wester RJ, Samera GJ, Walcott JR, et al. Molecular surveillance of Mycoplasmopsis bovis across dairy farms in Western Canada and 16s microbiome assessment in pneumonic calves. J Dairy Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42092549/

[2] Ahmadi A, Oma VS, Ånestad LM, et al. Genomic diversity and virulence of Pasteurella multocida in Norwegian calves. Microb Genom. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42257689/

[3] Abedien ZU, Lean IJ, Djordjevic SP, et al. Next-generation detection in bovine respiratory and enteric diseases: metagenomic and amplicon sequencing insights into microbial diversity. Front Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42022392/

[4] Russell T, Sulçe M, Hoda A, et al. Detection of viruses associated with bovine respiratory disease complex in samples collected from Albanian cattle during 2022/2023. Access Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42095138/

[5] Liu L, Xiang J, Shi Y, et al. Development and application of a dual RT-qPCR assay for the differential detection of bovine rhinitis virus genotypes A and B. J Virol Methods. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42248256/

[6] Buczinski S, Gomes V, Vergnes G, et al. Lung ultrasonography used as a diagnostic test for respiratory disease diagnosis in calves: systematic review and meta-analysis using a Bayesian latent-class modelling approach. J Dairy Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42114745/

[7] Sang H, Kim T, Kumar R, et al. Novel BPI3Vc-vectored chimeric BVDV antigens elicit broadly neutralizing antibodies in cattle. Front Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42233013/

[8] Wang Z, Fan X, Bai B, et al. Polyglutamine-Expanded Ataxin-3 Accelerates CFTR Degradation Through K63-Linked Ubiquitination to Exacerbate Microglial Inflammation. ASN Neuro. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42189036/

[9] Makratzakis LC, Velasco JA, Stegelmeier NC, et al. Peripheral leukocyte transcriptomic changes in preweaned Holstein heifer calves with varying stages of Bovine Respiratory Disease. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42133642/

[10] Liao J, Yang X, Li R, et al. Development of an indirect enzyme-linked immunosorbent assay based on the nucleocapsid protein of bovine parainfluenza virus type 3. Front Cell Infect Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42100657/

[11] Doğan E. Effects of diclofenac sodium and tilmicosin on cardiac biomarkers in calves with bovine respiratory disease